Speech Amplification Device Usage for Parkinson’s disease: A Survey of Speech-Language Pathologists

Thea Knowles, Kelly Gates, Helen Mach, Jeff Higginbotham, Thea Holder

Presented at the ASHA Convention

New Orleans, LA, November 18, 2022

Previous
Previous

Impact of Face Masks on Speech Intelligibility in Parkinson’s Disease: Clear and Loud Speech Strategies

Next
Next

Controlled effects of face masks and shields on spectral acoustics, speech intelligibility, and listening effort